View Press Releases
-
Certara Announces the Formation of a New Practice Area Focused on Global Health
PRINCETON, NJ - Jul 9, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that it has formed a new practice area called Certara Global Health (CGH) to focus its technological expertise on helping to achieve equity in health for all people worldwide
Jul 9, 2019
-
Bellicum Pharmaceuticals Announces Rivo-cel™ Achieves Primary Endpoint in Pediatric Registrational Trial
HOUSTON, TX - Jul 8, 2019 - Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced that the primary endpoint of event free survival at 180 days in its BP-004 European registration trial for rivo-cel (rivogenlecleucel) has been achieved
Jul 8, 2019
-
PHARMASEAL Launches Second Major Release of Engility CTMS
NOTTINGHAM, UNITED KINGDOM - Jul 8, 2019 - PHARMASEAL, a new provider of clinical trial management and governance solutions to enter the market, announces a second major release of its Engility CTMS platform
Jul 8, 2019
-
SEKISUI XenoTech Announces Enhanced Synergy in ADME Testing Services
KANSAS CITY, KS, UNITED STATES - Jul 2, 2019 - SEKISUI XenoTech is collaborating with the Drug Development Solutions Center to offer a full suite of nonclinical testing services specializing in the evaluation of Absorption, Distribution, Metabolism, and Excretion (ADME) in potential new drugs
Jul 2, 2019
-
MGI Responds to Illumina Lawsuits with Confidence in the Strength of its Patent Portfolio
SAN JOSE, CA - Jul 2, 2019 - MGI Responds to Illumina Lawsuits with Confidence in the Strength of its Patent PortfolioCalls for Fair Competition in the Gene Sequencing Market MGI, a subsidiary of BGI Group, expressed confidence in its core patent portfolio in the field of gene sequencing and vowed to fully support the industry to achieve higher quality, more cost-effective sequencing
Jul 2, 2019
-
Antibodies.com Raises £400,000 Pre-Seed Round to Help Researchers Discover More For Less
, CAMBRIDGE, UNITED KINGDOM - Jul 2, 2019 - Antibodies.com, a digital marketplace that enables life scientists to purchase critical research reagents at cost-effective prices from the primary manufacturers, today announced that is has raised £400,000 in pre-seed financing
Jul 2, 2019
-
Creative Diagnostics Launches Viral Antigens for Science Community
SHIRLEY, NY, UNITED STATES - Jul 1, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics announced that it has launched a series of viral antigens for biological research use, including Adenovirus, CMV, Coronavirus, Coxsackievirus, Dengue Virus, EBV, EV71, Ebola Virus, HAV, HBV and so on
Jun 30, 2019
-
Cofactor Joins FNIH Biomarkers Consortium to Add Predictive Immune Modeling Expertise as New Resource for Multidimensional Biomarker Discovery
BELFORD, NJ, US - Jun 28, 2019 - Cofactor Joins FNIH Biomarkers Consortium to Add Predictive Immune Modeling Expertise as New Resource for Multidimensional Biomarker Discovery-Contributing to both the Cancer and Inflammation and Immunity Steering Committees-SAN FRANCISCO--(BUSINESS WIRE)-- Cofactor Genomics, pioneers in the field of Predictive Immune Modeling, announced today that they have become a member of the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium with the goal of advancing the adoption of multidimensional biomarkers in cancer and immune-related diseases
Jun 28, 2019
-
NEW MONOCLONAL ANTIBODY FOR RUBELLA TESTING AVAILABLE FROM BINDING SITE
SAN DIEGO - Jun 28, 2019 - ~~San Diego, CA . . . . BINDING SITE'sIMMUNOLOGICALS GROUP is pleased to announce the addition of a new, purified monoclonal antibody to be used for the analysis and testing of the Rubella
Jun 28, 2019
-
BOC Sciences Upgrades Its Product Line Specially Targeted for Life Science Research
SHIRLEY, NY, UNITED STATES - Jun 27, 2019 - As a well-established chemical supplier based in New York, BOC Sciences announces to upgrade one of its product lines specially targeted for life science research, including small molecules in stem cell, carbohydrates, nucleosides & nucleotides as well as fluorescent probes
Jun 26, 2019
-
X4 Pharmaceuticals Initiates Pivotal Phase 3 Clinical Trial of Mavorixafor for the Treatment of WHIM Syndrome
CAMBRIDGE, MA, US - Jun 26, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced the initiation of 4WHIM, a pivotal Phase 3 global clinical trial of mavorixafor (X4P-001) for the treatment of WHIM (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis) syndrome, a rare, inherited, primary immunodeficiency disease
Jun 26, 2019
-
Creative Biolabs Provides Diabody Service to Customers for Research Use
ACCORD, NY - Jun 25, 2019 - June 25, 2019, as one of the most successful suppliers in the field of antibody production, Creative Biolabs developed diabody service to customers for both academic and clinical research use
Jun 25, 2019
-
Genedata Expands Collaboration with AstraZeneca on Deep Learning for High-Content Image Analysis
BASEL, SWITZERLAND - Jun 25, 2019 - Genedata, a leading provider of advanced software solutions for biopharmaceutical R&D, today announced a collaboration with AstraZeneca to automate high-content screening (HCS) image analysis using Genedata Imagence®
Jun 25, 2019
-
LabTwin’s AI-powered Digital Assistant Now Talks Back and Connects Data Sources in the Lab with New Open API
BERLIN, N/A, GERMANY - Jun 3, 2019 - LabTwin GmbH, the world's first voice and AI-powered digital lab assistant, today announced its new open API that will connect scientists with data sources both inside and outside of the lab
Jun 25, 2019
-
Certara Announces First Recipients of Certara-Monash University Industry Drug Development Fellowships
PRINCETON, NJ - Jun 25, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, and Monash University today announced the recipients of the inaugural Certara-Monash University Industry Drug Development Fellowships – Dr
Jun 25, 2019
-
Medherant positions itself for the next stage of its development with the appointment of a new CEO
COVENTRY, UK - Jun 25, 2019 - Medherant Limited (Medherant), the clinical-stage company developing innovative products for pain and CNS diseases using a unique transdermal delivery technology, TEPI Patch®, has appointed John Burt as Chief Executive Officer, effective 24 June 2019
Jun 25, 2019
-
Creative Proteomics Has Launched a Wide Range of Newly-developed Proteomics Analysis Services for Biologists
SHIRLEY, NY, US - Jun 25, 2019 - Creative Proteomics, a leading supplier in metabolomics services, has recently released its several newly-developed proteomics services to researchers
Jun 24, 2019
-
Positive Technologies launches PT Application Inspector Enterprise to create secure web applications
FRANGINGHAM, MA, UNITED STATES - Jun 24, 2019 - Positive Technologies today unveiled PT Application Inspector Enterprise (PT AI Enterprise), a solution that automatically detects vulnerabilities and offers security experts the verification tools they need to secure web applications
Jun 24, 2019
-
CD Genomics Announces Highly Sensitive and Accurate Genome Sequencing Services Related to Genome Research
SHIRLEY, NY - Jun 24, 2019 - SHIRLEY, NY, UNITED STATES – Jun 24, 2019 - CD Genomics, the USA-based genetic sequencing company and an expert in transcriptomics and next generation sequencing, announces the technical escalation of sequencing services, The updated service ranges include five: mitochondrial DNA sequencing, microbial whole genome sequencing, plasmid DNA sequencing, SMRT sequencing and bacterial genome sequencing, which are based on some of the most powerful platforms in this field with unrivaled accuracy and sensitivity
Jun 24, 2019
-
Steven Daniel joins Cofactor Genomics as Vice President of Business Development
SAN FRANCISCO, CA, UNITED STATES - Jun 20, 2019 - Cofactor Genomics today announced the appointment of Steven Daniel, PhD as Vice President of Business Development, overseeing the development and execution of the companys sales strategy and sales management
Jun 20, 2019